Clinical Trials Browser

Phase 1 × OTHER × Leukemia, B-Cell × Clear all

NCT01683279 2026-06-05

A Pediatric Trial of Genetically Modified Autologous T Cells Directed Against CD19 for Relapsed CD19+ Acute Lymphoblastic Leukemia

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT07511426 2026-05-28

U96-CAR-T-Cells For R/R B-ALL

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Recurrence, Leukemia, B-Cell

NCT02787369 2026-05-19

ACY-1215 in Combination With BCR Pathway Inhibitors in Relapsed CLL

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell

NCT03774654 2026-05-18

CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06208735 2026-04-03

CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

NCT07166549 2025-12-24

BaseCAR-01

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06345027 2025-12-16

CASEY

Phase 1 Not yet recruiting

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, T-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

NCT02650414 2025-12-12

CD22 Redirected Autologous T Cells for ALL

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Lymphoma, B-Cell

NCT02050347 2025-11-14

CARPASCIO

Phase 1 Active not recruiting

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, B-Cell

NCT05010564 2025-11-13

TRICAR-ALL

Phase 1 Recruiting

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell

NCT04260945 2022-03-08

CD19/CD20 Dual-CAR-T in B-cell Leukemia Patients

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT03605589 2021-04-01

Pembro + Blina Combination in Pediatric and Young Adult Patients With Relapsed/Refractory Acute Leukemia or Lymphoma

Phase 1 Withdrawn

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT04516551 2020-11-17

Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03599375 2019-02-26

Immunotherapy With CD19 CART-cells for B Cell Acute Lymphoblastic Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, B-Cell

NCT03576807 2018-07-03

The Clinical Research of Anti-CD20 CAR-T Cells in Patients With Refractory or Relapsed B Lymphocyte Lymphoma

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Recurrence, Leukemia, B-Cell, Lymphoma, B-Cell

NCT03463928 2018-03-13

A Feasibility and Safety Study of Concomitant Therapy With Allo-CAR-T Cells and Allo-HSCT in Patients With Relapse or Refractory Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01805375 2018-02-05

A Phase I Trial of DI-B4 in Patients With Advanced CD19 Positive Indolent B-cell Malignancies

Phase 1 Completed

LymphoidOther hematologic neoplasm

Waldenstrom Macroglobulinemia, Neoplasms, Leukemia, B-Cell, Lymphoma, B-Cell

NCT01400685 2018-01-25

Lenalidomide Plus Bendamustine and Rituximab for Untreated CLL/SLL

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01362452 2017-08-03

Infusion of Allogeneic Umbilical Cord Blood-Derived Cluster of Differentiation Antigen 19 (CD19)-Specific T Cells

Phase 1 Completed

LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02968472 2016-11-18

A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia

Phase 1 Unknown

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, B-Cell

NCT00990587 2015-06-22

Study Evaluating the Tolerance and Biologic Activity of Oral Ciclopirox Olamine in Patients With Relapsed or Refractory Hematologic Malignancy

Phase 1 Completed

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Anemia, Refractory, with Excess of Blasts, Blast Crisis, Hodgkin Disease, Recurrence, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Hematologic Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma